Delhi High Court Grants Interim Relief to AstraZeneca Against NPPA Overcharging Demand
AstraZeneca Pharma India Ltd 路 Others (Uncategorized) 路 02 Nov 2026, 5:21 pm
Delhi High Court Grants Interim Relief to AstraZeneca Against NPPA Overcharging Demand The Hon'ble High Court of Delhi, vide order dated 29th Oct'26, directed the National Pharmaceutical Pricing Authority (NPPA) to take no coercive steps against AstraZeneca Pharma India Limited until the next hearing on 11th Jan'27. The matter pertains to an NPPA notice alleging DPCO 2013 overcharging on Symbicort Turbuhaler 160/4.5 from May'16 to Nov'25. The interim relief stays recovery proceedings for approximately Rs 151.20 crore (Rs 151,19,66,035), comprising the alleged overcharged principal and accrued interest up to 30th Oct'26.
Original exchange filing (PDF)
More announcements from AstraZeneca Pharma India Ltd
- Please find the enclosed document of the Company as per the captioned subject. This is being resubmitted as the weblink was not correctly re-directing to the relevant web page in the earlier .... 路 17 Nov 2026
- Please find the enclosed intimation of the Company as per the captioned subject for your reference. 路 17 Nov 2026
- Please find the enclosed intimation of the Company as per the captioned subject for your reference. 路 07 Nov 2026
- AstraZeneca Pharma India Limited has informed the Exchange about General Updates 路 06 Nov 2026
- Please find the enclosed intimation of the Company as per the captioned subject for your reference. 路 06 Nov 2026
- Please find the enclosed intimation of the Company as per the captioned subject for your reference. 路 06 Nov 2026
- Please find the enclosed intimation of the Company as per the captioned subject for your reference. 路 05 Nov 2026
- AstraZeneca Pharma India Limited has informed the Exchange about Appointment/ Change in designation of Senior Management Personnel 路 05 Nov 2026
